Epigenetic mechanisms in chronic obstructive pulmonary disease

European Review for Medical and Pharmacological Sciences

Volumn 19, Issue 5, 2015, Pages 844-856

  Zong, D D ^a   Ouyang, R Y ^a   Chen, P ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Acetylation; COPD; DNA methylation; Epigenetics; Histone methylation; Phosphorylation; Ubiquitination

Indexed keywords

DNA; HISTONE; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE;

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DEACETYLATION; DNA METHYLATION; EPIGENETICS; HEREDITY; HISTONE ACETYLATION; HISTONE METHYLATION; HISTONE MODIFICATION; HISTONE PHOSPHORYLATION; HISTONE UBIQUITINATION; HUMAN; MOLECULAR PATHOLOGY; NONHUMAN; SUMOYLATION; ANIMAL; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS;

ANIMALS; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84942251911     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (169)

1. ITO K, BARNES PJ. COPD as a disease of accelerated lung aging. Chest 2009;135:173-180.
2. ORNEK T, TOR M, ALTIN R, ATALAR F, GEREDELI E, SOYLU O, ERBOY F. Clinical factors affecting the direct cost of patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease. Int J Med Sci 2012;9:285-290.
3. ACQUAAH-MENSAH GK, MALHOTRA D, VULIMIRI M, MCDERMOTT JE, BISWAL S. Suppressed expression of Tbox transcription factors is involved in senescence in chronic obstructive pulmonary disease. PLoS Comput Biol 2012;8:e1002597.
4. SHARMA PK, JOHRI S, MEHRA BL. Efficacy of Vasadi Syrup and Shwasaghna Dhuma in the patients of COPD (Shwasa Roga). Ayu 2010;31:48-52.
5. YANG JY, JIN J, ZHANG Z, ZHANG L, SHEN C. Integration microarray and regulation datasets for chronic obstructive pulmonary disease. Eur Rev Med Pharmacol Sci 2013, 17:1923-1931.
6. PANDEY R, SINGH M, SINGHAL U, GUPTA KB, AGGARWAL SK. Oxidative/Nitrosative stress and the pathobiology of chronic obstructive pulmonary disease. J Clin Diagn Res 2013;7:580-588.
7. SHAPIRO SD, INGENITO EP. The pathogenesis of chronic obstructive pulmonary disease: advances in the past 100 years. Am J Respir Cell Mol Biol 2005;32:367-372.
8. MARWICK JA, KIRKHAM PA, STEVENSON CS, DANAHAY H, GIDDINGS J, BUTLER K, DONALDSON K, MACNEE W, RAHMAN I. Cigarette smoke alters chromatin remodeling and induces proinflammatory genes in rat lungs. Am J Respir Cell Mol Biol 2004;31:633-642.
9. MCMILLAN DH, BAGLOLE CJ, THATCHER TH, MAGGIRWAR S, SIME PJ, PHIPPS RP. Lung-targeted overexpression of the NF-κB member RelB inhibits cigarette smoke-induced inflammation. Am J Pathol 2011;179:125-133.
10. SHEN N, GONG T, WANG JD, MENG FL, QIAO L, YANG RL, XUE B, PAN FY, ZHOU XJ, CHEN HQ, NING W, LI CJ. Cigarette smoke-induced pulmonary inflammatory responses are mediated by EGR-1/GGPPS/MAPK signaling. Am J Pathol 2011;178:110-118.
11. MROZ RM, NOPARLIK J, CHYCZEWSKA E, BRASZKO JJ, HOLOWNIA A. Molecular basis of chronic inflammation in lung diseases: new therapeutic approach. J Physiol Pharmacol 2007;58:453-460.
12. BARNES PJ. Targeting the epigenome in the treatment of asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc 2009;6:693-696.
13. YANG IV, SCHWARTZ DA. Epigenetic control of gene expression in the lung. Am J Respir Crit Care Med 2011;183:1295-1301.
14. SAKAO S, TATSUMI K. The importance of epigenetics in the development of chronic obstructive pulmonary disease. Respirology 2011;16:1056-1063.
15. SHANMUGAM MK, SETHI G. Role of epigenetics in inflammationassociated diseases. Subcell Biochem 2012;61:627-657.
16. BARNES PJ. Reduced histone deacetylase in COPD: clinical implications. Chest 2006;129:151-155.
17. ADCOCK IM. Glucocorticoid-regulated transcription factors. Pulm Pharmacol Ther 2001;14:211-219.
18. BARNES PJ, ADCOCK IM, ITO K. Histone acetylation and deacetylation: importance in inflammatory lung diseases. Eur Respir J 2005;25:552-563.
19. ADCOCK IM, TSAPROUNI L, BHAVSAR P, ITO K. Epigenetic regulation of airway inflammation. Curr Opin Immunol 2007;19:694-700.
20. ADCOCK IM, FORD P, ITO K, BARNES PJ. Epigenetics and airways disease. Respir Res 2006;7:21.
21. LANZUOLO C. Epigenetic alterations in muscular disorders. Comp Funct Genomics 2012;2012:256892.
22. BAYARSAIHAN D. Epigenetic mechanisms in inflammation. J Dent Res 2011;90:9-17.
23. CHIN SP, DICKINSON JL, HOLLOWAY AF. Epigenetic regulation of prostate cancer. Clin Epigenetics 2011;2:151-169.
24. REDDY MA, NATARAJAN R. Epigenetic mechanisms in diabetic vascular complications. Cardiovasc Res 2011;90:421-429.
25. ROBISON AJ, NESTLER EJ. Transcriptional and epigenetic mechanisms of addiction. Nat Rev Neurosci 2011;12:623-637.
26. KUZARIDES T. Chromatin modifications and their function. Cell 2007;128:693-705.
27. ALELU-PAZ R, ASHOUR N, GONZALEZ-CORPAS A, ROPERO S. DNA methylation, histone modifications, and signal transduction pathways: a close relationship in malignant gliomas pathophysiology. J Signal Transduct 2012;2012:956958.
28. MITCHELL MD, PONNAMPALAM AP, RICE GE. Epigenetic regulation of cytokine production in human amnion and villous placenta. Mediators Inflamm 2012;2012:159709.
29. GALLINARI P, DI MARCO S, JONES P, PALLAORO M, STEINKUHLER C. HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics. Cell Res 2007;17:195-211.
30. QIU W, BACCARELLI A, CAREY VJ, BOUTAOUI N, BACHERMAN H, KLANDERMAN B, RNNARD S, AGUSTI A, ANDERSON W, LOMAS DA, DEMEO DL. Variable DNA methylation is associated with chronic obstructive pulmonary disease and lung function. Am J Respir Crit Care Med 2012;185:373-381.
31. GUZMAN L, DEPIX MS, SALINAS AM, RLDAN R, AGUAYO F, SILVA A, VINET R. Analysis of aberrant methylation on promoter sequences of tumor suppressor genes and total DNA in sputum samples: a promising tool for early detection of COPD and lung cancer in smokers. Diagn Pathol 2012;7:87.
32. WAN ES, QIU W, BACCARELLI A, CAREY VJ, BACHERMAN H, RENNARD SI, AGUSTI A, ANDERSON W, LOMAS DA, DEMEO DL. Cigarette smoking behaviors and time since quitting are associated with differential DNA methylation across the human genome. Hum Mol Genet 2012;21:3073-3082.
33. MONICK MM, BEACH SR, PUME J, SEARS R, GERRARD M, BRODY GH, PHILIBERT RA. Coordinated changes in AHRR methylation in lymphoblasts and pulmonary macrophages from smokers. Am J Med Genet B Neuropsychiatr Genet 2012;159:141-151.
34. SIEDLINSKI M, KLANDERMAN B, SANDHAUS RA, BARKER AF, BRANTLY ML, EDEN E, MCELVANEY NG, RENNARD SI, STOCKS JM, STOLLER JK, STRANGE C, TURINO GM, CAMPBELL EJ, DEMEO DL. Association of cigarette smoking and CRP levels with DNA methylation in α-1 antitrypsin deficiency. Epigenetics 2012;7:720-728.
35. ITO K, ITO M, ELIOTT WM, COSIO B, CARAMORI G, KON OM, BARCZYK A, HAYASHI S, ADCOCK IM, HOGG JC, BARNES PJ. Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med 2005;352:1967-1976.
36. ADENUGA D, YAO H, MARCH TH, SEAGRAVE J, RAHMAN I. Histone deacetylase 2 is phosphorylated, ubiquitinated, and degraded by cigarette smoke. Am J Respir Cell Mol Biol 2009;40:464-473.
37. RAJENDRASOZHAN S, YANG SR, EDIRISINGHE I, YAO H, ADENUGA D, RAHMAN I. Deacetylases and NF-kappaB in redox regulation of cigarette smoke-induced lung inflammation: epigenetics in pathogenesis of COPD. Antioxid Redox Signal 2008;10:799-811.
38. ZHANG R, KANG KA, KIM KC, NA SY, CHANG WY, KIM GY, KIM HS, HYUN JW. Oxidative stress causes epigenetic alteration of CDX1 expression in colorectal cancer cells. Gene 2013;524:214-219.
39. O'HAGAN HM, WANG W, SEN S, DESTEFANO SHIELDS C, LEE SS, ZHANG YW, CLEMENTS EG, CAI Y, VAN NESTE L, EASWARAN H, CASERO RA, SEARS CL, BAYLIN SB. Oxidative damage targets complexes containing DNA methyltransferases, SIRT1, and polycomb members to promoter CpG Islands. Cancer Cell 2011;20:606-619.
40. KANG KA, ZHANG R, KIM GY, BAE SC, HYUN JW. Epigenetic changes induced by oxidative stress in colorectal cancer cells: methylation of tumor suppressor RUNX3. Tumour Biol 2012;33:403-412.
41. PATTERSON AJ, XIAO D, XIONG F, DIXON B, ZHANG L. Hypoxia-derived oxidative stress mediates epigenetic repression of PKCε gene in foetal rat hearts. Cardiovasc Res 2012;93:302-310.
42. BONVICINI F, MANARESI E, DI FURIO F, DE FALCO L, GALLINELLA G. Parvovirus b19 DNA CpG dinucleotide methylation and epigenetic regulation of viral expression. PLoS One 2012;7:e33316.
43. LI XQ, GUO YY, DE W. DNA methylation and microRNAs in cancer. World J Gastroenterol 2012;18:882-888.
44. REINIUS LE, ACEVEDO N, JOERINK M, PERSHAGEN G, DAHLEN SE, GRECO D, SODERHALL C, SCHEYNIUS A, KERE J. Differential DNA methylation in purified human blood cells: implications for cell lineage and studies on disease susceptibility. PLoS One 2012;7:e41361.
45. RAO JS, KELESHIAN VL, KLEIN S, RAPOPORT SI. Epigenetic modifications in frontal cor tex from Alzheimer's disease and bipolar disorder patients. Transl Psychiatry 2012;2:e132.
46. ORR BA, HAFFNER MC, NELSON WG, YEGNASUBRAMANIAN S, EBERHART CG. Decreased 5-hydroxymethylcytosine is associated with neural progenitor phenotype in normal brain and shorter survival in malignant glioma. PLoS One 2012;7:e41036.
47. CHEUNG P, LAU P. Epigenetic regulation by histone methylation and histone variants. Mol Endocrinol 2005;19:563-573.
48. LIU WR, SHI YH, PENG YF, FAN J. Epigenetics of hepatocellular carcinoma: a new horizon. Chin Med J (Engl) 2012;125:2349-2360.
49. ARAND J, SPIELER D, KARIUS T, BRANCO MR, MEILINGER D, MEISSNER A, JENUWEIN T, XU G, LEONHARDT H, WOLF V, WALTER J. In vivo control of CpG and Non-CpG DNA Methylation by DNA Methyltransferases. PLoS Genet 2012;8:e1002750.
50. CHESTNUT BA, CHANG Q, PRICE A, LESUISSE C, WONG M, MARTIN LJ. Epigenetic regulation of motor neuron cell death through DNA methylation. J Neurosci 2011;31:16619-16636.
51. BARTELS SJ, SPRUIJT CG, BRINKMAN AB, JANSEN PW, VERMEULEN M, STUNNENBERG HG. A SILAC-based screen for Methyl-CpG binding proteins identifies RBP-J as a DNA methylation and sequencespecific binding protein. PLoS One 2011;6:e25884.
52. PARRY L, CLARKE AR. The roles of the methyl-CpG binding proteins in cancer. Genes Cancer 2011;2:618-630.
53. MANDREKAR P. Epigenetic regulation in alcoholic liver disease. World J Gastroenterol 2011;17:2456-2464.
54. UEHARA E, TAKEUCHI S, YANG Y, FUKUMOTO T, MATSUHASHI Y, TAMURA T, MATSUSHITA M, NAGAI M, KOEFFLER HP, TASAKA T. Aberrant methylation in promoterassociated CpG islands of multiple genes in chronic myelogenous leukemia blast crisis. Oncol Lett 2012;3:190-192.
55. REAMON-BUETTNER SM, BORLAK J. Dissecting epigenetic silencing complexity in the mouse lung cancer suppressor gene Cadm1. PLoS One 2012;7:e38531.
56. WONG TS, GAO W, LI ZH, CHAN JY, HO WK. Epigenetic dysregulation in laryngeal squamous cell carcinoma. J Oncol 2012;2012:739461.
57. WATT F, MOLLOY PL. Cytosine methylation prevents binding to DNA of a HeLa cell transcription factor required for optimal expression of the adenovirus major late promoter. Genes Dev 1988;2:1136-1143.
58. ZHU WG, SRINIVASAN K, DAI Z, DUAN W, DRUHAN LI, DING H, YEE L, VILLALONA-CALERO MA, PLASS C, OTTERSON GA. Methylation of adjacent CpG sites affects Sp1/Sp3 binding and activity in the p21 (Cip1) promoter. Mol Cell Biol 2003;23:4056-4065.
59. WAN M, ZHAO K, LEE SS, FRANCKE U. MECP2 truncating mutations cause histone H4 hyperacetylation in Rett syndrome. Hum Mol Genet 2001;10:1085-1092.
60. ROBERTSON KD. DNA methylation and human disease. Nat Rev Genet 2005;6:597-610.
61. ZENG H, KONG X, PENG H, CHEN Y, CAI S, LUO H, CHEN P. Apoptosis and Bcl-2 family proteins, taken to chronic obstructive pulmonary disease. Eur Rev Med Pharmacol Sci 2012;16:711-727.
62. AOSHIBA K. Roles of apoptosis, cell senescence, and DNA damage in the pathogenetic mechanism of COPD. Nihon Rinsho 2011;69:1754-1757.
63. COMER DM, KIDNEY JC, ENNIS M, ELBORN JS. Airway epithelial cell apoptosis and inflammation in COPD, smokers and nonsmokers. Eur Respir J 2013;41:1058-1067.
64. FARKAS L, FARKAS D, WARBURTON D, GAULDIE J, SHI W, STAMPFLI MR, VOELKEL NF, KOLB M. Cigarette smoke exposure aggravates air space enlargement and alveolar cell apoptosis in Smad3 knockout mice. Am J Physiol Lung Cell Mol Physiol 2011;301:L391-L401.
65. NAKANISHI K, TAKEDA Y, TETSUMOTO S, IWASAKI T, TSUJINO K, KUHARA H, JIN Y, NAGATOMO I, KIDA H, GOYA S, KIJIMA T, MAEDA N, FUNAHASHI T, SHIMOMURA I, TACHIBANA I, KAWASE I. Involvement of endothelial apoptosis underlying chronic obstructive pulmonary disease-like phenotype in adiponectinnull mice: implications for therapy. Am J Respir Crit Care Med 2011;183:1164-1175.
66. YANG M, CHEN P, PENG H, SHEN Q, CHEN Y. Cytochrome C oxidase expression and endothelial cell apoptosis in lungs of patients with chronic obstructive pulmonary disease. Zhonghua Jie He He Hu Xi Za Zhi 2010;33:665-669.
67. YANG M, PENG H, CHEN P. Involvement of DNA methylation in endothelial apoptosis induced by cigarette smoke extract. Eur Respir J 2010;36(Supplement 54):20th ERS Annual Congress, Barcelona, Spain, 18th-22nd September 2010.
68. PENG H, YANG M, CHEN P. The effect of mtTFA methylation in the pathogenesis of pulmonary vascular endothelial cell apoptosis of chronic obstructive pulmonary disease. Eur Respir J 2010;36(Supplement 54):20th ERS Annual Congress, Barcelona, Spain, 18th-22nd September 2010.
69. YAP JL, WORLIKAR S, MACKERELL AD JR, SHAPIRO P, FLETCHER S. Small-molecule inhibitors of the ERK signaling pathway: Towards novel anticancer therapeutics. Chem Med Chem 2011;6:38-48.
70. XIAO J, WANG K, FENG YL, CHEN XR, XU D, ZHANG MK. Role of extracellular signal-regulated kinase 1/2 in cigarette smoke-induced mucus hypersecretion in a rat model. Chin Med J (Engl) 2011;124:3327-3333.
71. LIU K, LIU XS, YU MQ, XU YJ. Change of extracellular signal-regulated kinase expression in pulmonary arteries from smokers with and without chronic obstructive pulmonary disease. Exp Lung Res 2013;39:162-172.
72. PARK JW, YOON JY, KIMYJ, KYUNG SY, LEE SP, JEONG SH, MOON C. Extracellular signal-regulated kinase (ERK) inhibition attenuates cigarette smoke extract (CSE) induced-death inducing signaling complex (DISC) formation in human lung fibroblasts (MRC-5) cells. J Toxicol Sci 2010;35:33-39.
73. HSU CL, WU YL, TANG GJ, LEE TS, KOU YR. Ginkgo biloba extract confers protection from cigarette smoke extract-induced apoptosis in human lung endothelial cells: Role of heme oxygenase-1. Pulm Pharmacol Ther 2009;22:286-296.
74. OELKE K, RICHARDSON B. Decreased T cell ERK pathway signaling may contribute to the development of lupus through effects on DNA methylation and gene expression. Int Rev Immunol 2004;23:315-331
75. LU R, WANG X, CHEN ZF, SUN DF, TIAN XQ, FANG JY. Inhibition of the extracellular signal-regulatied kinase/mitogen-actived protein kinase pathway decrease DNA methylation in colon cancer cell. J Biol Chem 2007;282:12249-12259
76. CHUNG S, SUNDAR IK, HWANG JW, YULL FE, BLACKWELL TS, KINNULA VL, BULGER M, YAO H, RAHMAN I. NF-κB inducing kinase, NIK mediates cigarette smoke/TNFα-induced histone acetylation and inflammation through differential activation of IKKs. PLoS One 2011;6:e23488.
77. RAJENDRASOZHAN S, CHUNG S, SUNDAR IK, YAO H, RAHMAN I. Targeted disruption of NF-{kappa}B1 (p50) augments cigarette smoke-induced lung inflammation and emphysema in mice: a critical role of p50 in chromatin remodeling. Am J Physiol Lung Cell Mol Physiol 2010;298:L197-L209.
78. SUNDAR IK, MULLAPUDI N, YAO H, SPIVACK SD, RAHMAN I. Lung cancer and its association with chronic obstructive pulmonary disease: update on nexus of epigenetics. Curr Opin Pulm Med 2011;17:279-85.
79. YANG SR, VALVO S, YAO H, KODE A, RAJENDRASOZHAN S, EDIRISINGHE I, CAITO S, ADENUGA D, HENRY R, FROMM G, MAGGIRWAR S, LI JD, BULGER M, RAHMAN I. IKK alpha causes chromatin modification on pro-inflammatory genes by cigarette smoke in mouse lung. Am J Respir Cell Mol Biol 2008;38:689-698.
80. GHIZZONI M, HAISMA HJ, MAARSINGH H, DEKKER FJ. Histone acetyltransferases are crucial regulators in NF-κB mediated inflammation. Drug Discov Today 2011;16:504-511.
81. SUNDAR IK, CAITO S, YAO H, RAHMAN I. Oxidative stress, thiol redox signaling methods in epigenetics. Methods Enzymol 2010;474:213-244.
82. RAHMAN I, MARWICK J, KIRKHAM P. Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NF-kappaB and pro-inflammatory gene expression. Biochem Pharmacol 2004;68:1255-1267.
83. WANG YL, FAIOLA F, MARTINEZ E. Purification of multiprotein histone acetyltransferase complexes. Methods Mol Biol 2012;809:427-443.
84. REKOWSKI MW, GIANNIS A. Histone acetylation modulation by small molecules: a chemical approach. Biochim Biophys Acta 2010;1799:760-767.
85. BEDFORD DC, BRINDLE PK. Is histone acetylation the most important physiological function for CBP and p300? Aging (Albany NY) 2012;4:247-255.
86. ESCOBAR J, PEREDA J, LOPEZ-RODAS G, SASTRE J. Redox signaling and histone acetylation in acute pancreatitis. Free Radic Biol Med 2012;52:819-837.
87. RAHMAN I. Oxidative stress, chromatin remodeling and gene transcription in inflammation and chronic lung diseases. J Biochem Mol Biol 2003;36:95-109.
88. RAJENDRASOZHAN S, YAO H, RAHMAN I. Current perspectives on role of chromatin modifications and deacetylases in lung inflammation in COPD. COPD 2009;6:291-297.
89. CAO D, BROMBERG PA, SAMET JM. COX-2 expression induced by diesel particles involves chromatin modification and degradation of HDAC1. Am J Respir Cell Mol Biol 2007;37:232-239.
90. PENG H, CHEN P, CAI Y, CHEN Y, WU QH, LI Y, ZHOU R, FANG X. Endothelin-1 increases expression of cyclooxygenase-2 and production of interlukin-8 in hunan pulmonary epithelial cells. Peptides 2008;29:419-424.
91. CLOCCHIATTI A, FLOREAN C, BRANCOLINI C. Class IIa HDACs: from important roles in differentiation to possible implications in tumourigenesis. J Cell Mol Med 2011;15:1833-1846.
92. KHAN O, LA THANGUE NB. HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications. Immunol Cell Biol 2012;90:85-94.
93. SEGRE CV, CHIOCCA S. Regulating the regulators: the post-translational code of class I HDAC1 and HDAC2. J Biomed Biotechnol 2011;2011:690848.
94. STEIN S, MATTER CM. Protective roles of SIRT1 in atherosclerosis. Cell Cycle 2011;10:640-647.
95. BRADLEY EW, MCGEE-LAWRENCE ME, WESTENDORF JJ. Hdac-mediated control of endochondral and intramembranous ossification. Crit Rev Eukaryot Gene Expr 2011;21:101-113.
96. LEE DY, LEE CI, LIN TE, LIM SH, ZHOU J, TSENG YC, CHIEN S, CHIU JJ. Role of histone deacetylases in transcription factor regulation and cell cycle modulation in endothelial cells in response to disturbed flow. Proc Natl Acad Sci U S A 2012;109:1967-1972.
97. YAO H, RAHMAN I. Current concepts on oxidative/carbonyl stress, inflammation and epigenetics in pathogenesis of chronic obstructive pulmonary disease. Toxicol Appl Pharmacol 2011;254:72-85.
98. ISAJEVS S, TAIVANS I, SVIRINA D, STRAZDA G, KOPEIKA U. Patterns of inflammatory responses in large and small airways in smokers with and without chronic obstructive pulmonary disease. Respiration 2011;81:362-371.
99. CHEN Y, HUANG P, AI W, LI X, GUO W, ZHANG J, YANG J. Histone deacetylase activity is decreased in peripheral blood monocytes in patients with COPD. J Inflamm (Lond) 2012;9:10.
100. ITO K, CHARRON CE, ADCOCK IM. Impact of protein acetylation in inflammatory lung diseases. Pharmacol Ther 2007;116:249-265.
101. RAHMAN I, GILMOUR PS, JIMENEZ LA, MACNEE W. Oxidative stress and TNF-alpha induce histone acetylation and NF-kappaB/AP-1 activation in alveolar epithelial cells: potential mechanism in gene transcription in lung inflammation. Mol Cell Biochem 2002;234-235:239-248.
102. MEJA KK, RAJENDRASOZHAN S, ADENUGA D, BISWAS SK, SUNDAR IK, SPOONER G, MARWICK JA, CHAKRAVARTY P, FLETCHER D, WHITTAKER P, MEGSON IL, KIRKHAM PA, RAHMAN I. Curcumin restores corticosteroid function in monocytes exposed to oxidants by maintaining HDAC2. Am J Respir Cell Mol Biol 2008;39:312-323.
103. MOODIE FM, MARWICK JA, ANDERSON CS, SZULAKOWSKI P, BISWAS SK, BAUTER MR, KILTY I, RAHMAN I. Oxidative stress and cigarette smoke alter chromatin remodeling but differentially regulate NF-kappaB activation and proinflammatory cytokine release in alveolar epithelial cells. FASEB J, 2004;18:1897-1899.
104. ADCOCK IM, ITO K, BARNES PJ. Histone deacetylation: an important mechanism in inflammatory lung diseases. COPD, 2005;2:445-455.
105. MALHOTRA D, THIMMULAPPA RK, MERCADO N, ITO K, KOMBAIRAJU P, KUMAR S, MA J, FELLER-KOPMAN D, WISE R, BARNES P, BISWAL S. Denitrosylation of HDAC2 by targeting Nrf2 restores glucocorticosteroid sensitivity in macrophages from COPD patients. J Clin Invest 2011;121:4289-4302.
106. ITO K, YAMAMURA S, ESSILFIE-QUAYE S, COSIO B, ITO M, BARNES PJ, ADCOCK IM. Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression. J Exp Med 2006;203:7-13.
107. ADCOCK IM, ITO K. Glucocorticoid pathways in chronic obstructive pulmonary disease therapy. Proc Am Thorac Soc 2005;2:313-319.
108. MURRAY K. The occurrence of ε-N-methyl lysine in histones in histones. Biochemistry, 1964;3:10-15.
109. BARSKI A, CUDDAPAH S, CUI K, ROH TY, SCHONES DE, WANG Z, WEI G, CHEPELEV I, ZHAO K. High-resolution profiling of histone methylations in the human genome. Cell 2007;129:823-837.
110. BAUER UM, DAUJAT S, NIELSEN SJ, NIGHTINGALE K, KOUZARIDES T. Methylation at arginine 17 of histone H3 is linked to gene activation. EMBO Rep 2002;3:39-44.
111. GUCCIONE E, BASSI C, CASADIO F, MARTINATO F, CESARONI M, SCHUCHLAUTZ H, LUSCHER B, AMATI B. Methylation of histone H3R2 by PRMT6 and H3K4 by an MLL complex are mutually exclusive. Nature 2007;449:933-937.
112. MIRANDA TB, WEBB KJ, EDBERG DD, REEVES R, CLARKE S. Protein arginine methyltransferase 6 specifically methylates the nonhistone chromatin protein HMGA1a. Biochem Biophys Res Commun 2005;336:831-835.
113. ZAKRZEWICZ D, ZAKRZEWICZ A, PREISSNER KT, MARKART P, WYGRECKA M. Protein arginine methyltransferases (PRMTs): promising targets for the treatment of pulmonary disorders. Int J Mol Sci 2012;13:12383-12400.
114. FONTAN N, GARCIA-DOMINGUEZ P, ALVAREZ R, DE LERA AR. Novel symmetrical ureas as modulators of protein arginine methyl transferases. Bioorg Med Chem 2013;21:2056-2067.
115. FAN Q, MIAO J, CUI L, CUI L. Characterization of PRMT1 from Plasmodium falciparum. Biochem J 2009;421:107-118
116. ZAKRZEWICZ D, EICKELBERG O. From arginine methylation to ADMA: a novel mechanism with therapeutic potential in chronic lung diseases. BMC Pulm Med 2009;9:5.
117. ONAT A, HERGENC G, CAN G, KARABULUT A. Serum asymmetric dimethylarginine levels among Turks: association with metabolic syndrome in women and tendency to decrease in smokers. Turk Kardiyol Dern Ars 2008;36:7-13.
118. EID HM, ARNESEN H, HJERKINN EM, LYBERG T, SELJEFLOT I. Relationship between obesity, smoking, and the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine. Metabolism 2004;53:1574-1579.
119. MAAS R, SCHULZE F, BAUMERT J, LOWEL H, HAMRAZ K, SCHWEDHELM E, KOENIG W, BOGER RH. Asymmetric dimethylarginine, smoking, and risk of coronary hear t disease in apparently healthy men: prospective analysis from the population-based Monitoring of Trends and Determinants in Cardiovascular Disease/Kooperative Gesundheitsforschung in der Region Augsburg study and experimental data. Clin Chem 2007;53:693-701.
120. ZHANG WZ, VENARDOS K, CHIN-DUSTING J, KAYE DM. Adverse effects of cigarette smoke on NO bioavailability: role of arginine metabolism and oxidative stress. Hypertension 2006;48:278-285.
121. YILDIRIM AQ, KONIGSHOFF M, WANG Q, EICKELBERG O. Expression Profiling Of Protein Arginine Methyltransferase (Prmt) Isoforms In Chronic Obstructive Pulmonary Disease (COPD). Am J Respir Crit Care Med 2010;181:A4954.
122. KOHSE K, WANG Q, STRITZKE S, KONIGSHOFF M, EICKELBERG O, YILDIRIM AO. Protein Arginine Methyltransferases (prmt) are involved In Th17 cell differentiation. Am J Respir Crit Care Med 2011;183:A4399.
123. YILDIRIM AO, BULAU P, ZAKRZEWICZ D, KITOWSKA KE, WEISSMANN N, GRIMMINGER F, MORTY RE, EICKELBERG O. Increased protein arginine methylation in chronic hypoxia: role of protein arginine methyltransferases. Am J Respir Cell Mol Biol 2006;35:436-443.
124. BOGER RH, SYDOW K, BORLAK J, THUM T, LENZEN H, SCHUBERT B, TSIKAS D, BODE-BOGER SM. LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases. Circ Res 2000;87:99-105.
125. ANDRESEN E, GUNTHER G, BULLWINKEL J, LANGE C, HEINE H. Increased expression of beta-defensin 1 (DEFB1) in chronic obstructive pulmonary disease. PLoS One 2011;6:e21898.
126. OKI M, AIHARA H, ITO T. Role of histone phosphorylation in chromatin dynamics and its implications in diseases. Subcell Biochem 2007;41:319-336.
127. BANNISTER AJ, KOUZARIDES T. Regulation of chromatin by histone modifications. Cell Res 2011;21:381-395.
128. SUGIYAMA K, SUGIURA K, HARA T, SUGIMOTO K, SHIMA H, HONDA K, FURUKAWA K, YAMASHITA S, URANO T. Aurora-B associated protein phosphatases as negative regulators of kinase activation. Oncogene 2002;21:3103-3111.
129. GOTO H, YASUI Y, NIGG EA, INAGAKI M. Aurora-B phosphorylates Histone H3 at serine28 with regard to the mitotic chromosome condensation. Genes Cells 2002;7:11-17.
130. LIOKATIS S, STUTZER A, ELSASSER SJ, THEILLET FX, KLINGBERG R, VAN ROSSUM B, SCHWARZER D, ALLIS CD, FISCHLE W, SELENKO P. Phosphorylation of histone H3 Ser10 establishes a hierarchy for subsequent intramolecular modification events. Nat Struct Mol Biol 2012;19:819-823.
131. KERSUL AL, IGLESIAS A, RIOS A, NOGUERA A, FORTEZA A, SERRA E, AGUSTI A, COSIO BG. Molecular mechanisms of inflammation during exacerbations of chronic obstructive pulmonary disease. Arch Bronconeumol 2011;47:176-183.
132. GAGLIARDO R, CHANEZ P, PROFITA M, BONANNO A, ALBANO GD, MONTALBANO AM, POMPEO F, GAGLIARDO C, MERENDINO AM, GJOMARKAJ M. IκB kinase-driven nuclear factor-κB activation in patients with asthma and chronic obstructive pulmonary disease. J Allergy Clin Immunol 2011;128:635-645. e1-2.
133. SUNDAR IK, CHUNG S, HWANG JW, LAPEK JD JR, BULGER M, FRIEDMAN AE, YAO H, DAVIE JR, RAHman I. Mitogen- and stress-activated kinase 1 (MSK1) regulates cigarette smoke-induced histone modifications on NF-κB-dependent genes. PLoS One 2012;7:e31378.
134. BARNES PJ. Alveolar macrophages as orchestrators of COPD. COPD 2004;1:59-70.
135. GRAFF JW, POWERS LS, DICKSON AM, KIM J, REISETTER AC, HASSAN IH, KREMENS K, GROSS TJ, WILSON ME, MONICK MM. Cigarette smoking decreases global microRNA expression in human alveolar macrophages. PLoS One 2012;7:e44066.
136. RENDA T, BARALDO S, PELAIA G, BAZZAN E, TURATO G, PAPI A, MAESTRELLI P, MASELLI R, VATRELLA A, FABBRI LM, ZUIN R, MARSICO SA, SAETTA M. Increased activation of p38 MAPK in COPD. Eur Respir J 2008;31:62-69.
137. SMITH SJ, FENWICK PS, NICHOLSON AG, KIRSCHENBAUM F, FINNEY-HAYWARD TK, HIGGINS LS, GIEMBYCZ MA, BARNES PJ, DONNELLY LE. Inhibitory effect of p38 mitogen-activated protein kinase inhibitors on cytokine release from human macrophages. Br J Pharmacol 2006;149:393-404.
138. KOCH A, GIEMBYCZ M, ITO K, LIM S, JAZRAWI E, BARNES PJ, ADCOCK I, ERDMANN E, CHUNG KF. Mitogen-activated protein kinase modulation of nuclear factorkappaB-induced granulocyte macrophagecolonystimulating factor release from human alveolar macrophages. Am J Respir Cell Mol Biol 2004;30:342-349.
139. RAHMAN I. Oxidative stress in pathogenesis of chronic obstructive pulmonary disease: cellular and molecular mechanisms. Cell Biochem Biophys 2005;43:167-188.
140. CARON MA, DEBIGARE R, DEKHUIJZEN PN, MALTAIS F. Diaphragm and skeletal muscle dysfunction in COPD. Rev Mal Respir 2011;28:1250-1264.
141. JU CR, CHEN RC. Serum myostatin levels and skeletal muscle wasting in chronic obstructive pulmonary disease. Respir Med 2012;106:102-108.
142. DOUCET M, DUBE A, JOANISSE DR, DEBIGARE R, MICHAUD A, PARE ME, VAILLANCOURT R, FRECHETTE E, MALTAIS F. Atrophy and hypertrophy signalling of the quadriceps and diaphragm in COPD. Thorax 2010;65:963-970.
143. SAKUMA K, YAMAGUCHI A. Sarcopenia and cachexia: the adaptations of negative regulators of skeletal muscle mass. J Cachexia Sarcopenia Muscle 2012;3:77-94.
144. HUSSAIN SN, SANDRI M. Role of autophagy in COPD skeletal muscle dysfunction. J Appl Physiol 2013;114:1273-1281.
145. FERMOSELLE C, RABINOVICH R, AUSIN P, PUIG-VILANOVA E, CORONELL C, SANCHEZ F, ROCA J, GEA J, BARREIRO E. Does oxidative stress modulate limb muscle atrophy in severe COPD patients? Eur Respir J 2012;40:851-862.
146. DEBIGARE R, COTE CH, MALTAIS F. Ubiquitination and proteolysis in limb and respiratory muscles of patients with chronic obstructive pulmonary disease. Proc Am Thorac Soc 2010;7:84-90.
147. WUST RC, DEGENS H. Factors contributing to muscle wasting and dysfunction in COPD patients. Int J Chron Obstruct Pulmon Dis 2007;2:289-300.
148. LIU Q, XU WG, LUO Y, HAN FF, YAO XH, YANG TY, ZHANG Y, PI WF, GUO XJ. Cigarette smoke-induced skeletal muscle atrophy is associated with upregulation of USP-19 via p38 and ERK MAPKs. J Cell Biochem 2011;112:2307-2316.
149. OTTENHEIJM CA, HEUNKS LM, LI YP, JIN B, MINNAARD R, VAN HEES HW, DEKHUIJZEN PN. Activation of the ubiquitin-proteasome pathway in the diaphragm in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006;174:997-1002.
150. OTTENHEIJM CA, HEUNKS LM, SIECK GC, ZHAN WZ, JANSEN SM, DEGENS H, DE BOO T, DEKHUIJZEN PN. Diaphragm dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;172:200-205.
151. OTTENHEIJM CA, HEUNKS LM, DEKHUIJZEN RP. Diaphragm adaptations in patients with COPD. Respir Res 2008;9:12.
152. TESTELMANS D, CRUL T, MAES K, AGTEN A, CROMBACH M, DECRAMER M, GAYAN-RAMIREZ G. Atrophy and hypertrophy signalling in the diaphragm of patients with COPD. Eur Respir J 2010;35:549-556.
153. ZOU C, ELLIS BM, SMITH RM, CHEN BB, ZHAO Y, MALLAMPALLI RK. Acyl-CoA: lysophosphatidylcholine acyltransferase I (Lpcat1) catalyzes histone protein O-palmitoylation to regulate mRNA synthesis. J Biol Chem 2011;286:28019-28025.
154. ZOU C, BUTLER PL, COON TA, SMITH RM, HAMMEN G, ZHAO Y, CHEN BB, MALLAMPALLI RK. LPS impairs phospholipid synthesis by triggering beta-transducin repeat-containing protein (beta-TrCP) - mediated polyubiquitination and degradation of the surfactant enzyme acyl-CoA: lysophosphatidylcholine acyltransferase I (LPCAT1). J Biol Chem 2011;286:2719-2727.
155. KIM SY, LEE JH, HUH JW, RO JY, OH YM, LEE SD, AN S, LEE YS. Cigarette smoke induces Akt protein degradation by the ubiquitin-proteasome system. J Biol Chem 2011;286:31932-31943.
156. LIU TB, XUE C. The Ubiquitin-Proteasome System and F-box Proteins in Pathogenic Fungi. Mycobiology 2011;39:243-248.
157. KIM JH, PARK KC, CHUNG SS, BANG O, CHUNG CH. Deubiquitinating enzymes as cellular regulators. J Biochem 2003;134:9-18.
158. D'ARCY P, LINDER S. Proteasome deubiquitinases as novel targets for cancer therapy. Int J Biochem Cell Biol 2012;44:1729-1738.
159. LAU AW, FUKUSHIMA H, WEI W. The Fbw7 and beta-TRCP E3 ubiquitin ligases and their roles in tumorigenesis. Front Biosci 2012;17:2197-2212.
160. SINGH RK, GONZALEZ M, KABBAJ MH, GUNJAN A. Novel E3 ubiquitin ligases that regulate histone protein levels in the budding yeast Saccharomyces cerevisiae. PLoS One 2012;7:e36295.
161. GATTI M, PINATO S, MASPERO E, SOFFIENTINI P, POLO S, PENENGO L. A novel ubiquitin mark at the N-terminal tail of histone H2As targeted by RNF168 ubiquitin ligase. Cell Cycle 2012;11:2538-2544.
162. CAO J, YAN Q. Histone ubiquitination and deubiquitination in transcription, DNA damage response, and cancer. Front Oncol 2012;2:26.
163. WRIGHT DE, WANG CY, KAO CF. Histone ubiquitylation and chromatin dynamics. Front Biosci 2012;7:1051-1078.
164. KIM J, GUERMAH M, MCGINTY RK, LEE JS, TANG Z, MILNE TA, SHILATIFARD A, MUIR TW, ROEDER RG. RAD6-Mediated transcription-coupled H2B ubiquitylation directly stimulates H3K4 methylation in human cells. Cell 2009;137:459-471.
165. OSLEY MA. Regulation of histone H2A and H2B ubiquitylation. Brief Funct Genomic Proteomic 2006;5:179-189.
166. GUTIERREZ L, OKTABA K, SCHEUERMANN JC, GAMBETTA MC, LY-HARTIG N, MULLER J. The role of the histone H2A ubiquitinase Sce in Polycomb repression. Development 2012;139:117-127.
167. WU CY, KANG HY, YANG WL, WU J, JEONG YS, WANG J, CHAN CH, LEE SW, ZHANG X, LAMOTHE B, CAMPOS AD, DARNAY BG, LIN HK. Critical role of monoubiquitination of histone H2AX protein in histone H2AX phosphorylation and DNA damage response. J Biol Chem 2011;286:30806-30815.
168. FAUCHER D, WELLINGER RJ. Methylated H3K4, a transcription-associated histone modification, is involved in the DNA damage response pathway. PLoS Genet 2010;6:e1001082.
169. URASAKI Y, HEATH L, XU CW. Coupling of glucose deprivation with impaired histone H2B monoubiquitination in tumors. PLoS One 2012;7:e36775.